Tsai-Ching Hsu has done his Ph.D in Institute of Medicine,Chung Shan Medical University, Taiwan.Tsai-Ching Hsu presently working as Director, Immunology Research Center, Chung Shan Medical University, Taiwan and Professor in Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taiwan. He has Published good number of publications.


Area of Interest

3)Infection and Immunity
4)Rheumatic disease

top publication

1)Tsay GJ, Wang CL, Chen TY, Huang CN, Hsu TC. (1996) SS-A/Ro antibodies in Chinese patients with systemic lupus erythematosus and Sjogren’s syndrome. J Formosan Med Asssoc 95(12): 905-10.

2)Hsu TC, Lee TL, Tsay GJ. (1997) Autoantigens components recognizable by scleroderma sera are exported via ectocytosis of fibroblasts. Rheumatology (Oxford) 36: 1038-44.

3)Huang CN, Lo CM, Hsu TC, Tsay GJ. (1999) Sera from scleroderma patients inhibit the fibroblast micromotions monitored electrically. J Rheumatol 26(6): 1312-7.

4)Tzang BS, Chen TY, Hsu TC, Liu YC, Tsay GJ. (1999) Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infections. Ann Rheum Dis 58(10): 630-4.

5)Kuo Chou TN, Hsu TC, Chen RM, Lin LI, Tsay GJ. (2000) Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCLA). Lupus 9: 551-4.

6)Fu HL, Hsu TC, Chang CC, Tsay GJ. (2001) Antigenic specificity of anti-neutrophil cytoplasmic antibody. J Formosan Med Asssoc 100(1): 35-9.

7)Hsu TC, Tsay GJ. (2001) Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford). 40(2): 152-7.

8)Wu YY, Hsu TC, Chen TY, Liu TC, Liu GY, Lee YJ, Tsay GJ. (2002) Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are the major autoantigens in hepaitis C virus (HCV) infection. Clin Exp Immunol 128: 347-52.

9)Huang CN, Hsu TC, Chou HH, Tsay GJ. (2004). Prevalence of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in patients with Graves’ disease treated with propylthiouracil and methimazole in Taiwan. J Formosan Med Asssoc 103(4): 274-9.

10)Huang CN, Hsu TC, Chou HH, Tsay GJ. (2004). ANA, Anti-DNA, and aCL in Graves’ Disease Patients treated with Propyluracil or Methimazole. Lupus 13: 450-4.

11)Hsu TC, Wu WJ, Chen MC, and Tsay GJ. (2004). Human parvovirus B19 nonstructural protein (NS1) induces apoptosis through mitochondria cell death pathway in monkey epithelial COS-7 cells. Scand J Infect Dis 36: 570-7.

12)Hsu TC, Chen TY, Lin MC, Tzang BS, and Tsay GJ. (2005). Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroenterol Hepatol 20(5): 733-8.

13)Hsu TC, Chang CH, Lin MC, Liu ST, Yen TJ, and Tsay GJ. (2006). Anti-CENP-H antibodies in patients with Sjogren’s syndrome. Rheumatol Int 26: 298-303.

14)Hsu TC*, Tsay GJ, Chen TY, Liu YC, Tzang BS*. (2006) Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection. Clin Exp Immunol 144: 110–116.

15)Hsu TC, Tzang BS, Huang CN, Lee YJ, Liu GY, Chen MC, Tsay GJ. (2006) Increased expression and secretion of IL-6 in human parvovirus B19 nonstructural protein (NS1) transfected COS-7 epithelial cells. Clin Exp Immunol 144:152–157.

16)Hsu TC, Chiang SY, Huang CY, Tsay GJ, Yang CW, Huang CN, Tzang BS*. (2007) Beneficial effects of treatment with transglutaminases inhibitor cystamine on macrophage response in NZB/W F1 mice. Exp Biol Med (Maywood) 232 (2): 195-203.